We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Following a consultation process, the General Pharmaceutical Council has approved an amended framework for revalidation and set a timetable for phasing it in.